Thermage FLX 900 Shots Hongdae at RE:BERRY — Full Face + Neck RF Lifting

Why 900 Shots — Monopolar RF Coverage for Face and Neck

The Thermage FLX 900-shot package delivers 900 monopolar RF pulses, enough to cover the full face plus the neck in a single session. Thermage FLX heats the dermis capacitively to 65-75°C through a calibrated tip while a cryogen spray protects the surface, triggering immediate collagen contraction and neocollagenesis over 90-180 days. A foundational peer-reviewed study by Fitzpatrick et al. (2003) on monopolar RF demonstrated measurable periorbital tightening in 86% of 86 treated subjects. This radiofrequency evidence base is the same regardless of clinic location, and the higher 900-shot count means the neck and jawline receive the same dense coverage as the cheeks at RE:BERRY Hongdae.

FDA-Cleared RF at 900 Shots: Peer-Reviewed Clinical Evidence

Thermage holds FDA clearance for non-invasive treatment of wrinkles based on multiple peer-reviewed monopolar RF trials that support the thermage flx 900 shots protocol. Dover et al. (2005) reported that a single-pass, multiple-pass radiofrequency algorithm improved comfort and efficacy across 5,700 treatments — shot density matters for uniform results. Finzi and Spangler (2005) documented multipass monopolar RF improving lower-face and neck laxity in 47 patients with 92% satisfaction, directly validating the neck coverage that 900 shots provide at RE:BERRY Hongdae. Biesman et al. (2006) confirmed RF safety across 72 subjects.

The latest-generation Thermage FLX adds AccuREP impedance tuning and a 16% larger tip than prior models, so 900 shots cover the face and neck faster with even radiofrequency delivery. The Thermage FLX 900-shot session pairs facial and submental tightening, and the clinic also offers a 600-shot face-only option for those who do not need neck coverage. Hsu and Kaminer (2003) reviewed nonablative RF mechanisms, documenting consistent dermal collagen tightening that underpins the radiofrequency evidence base behind every shot count.

Histological analysis by Zelickson et al. (2004) showed monopolar RF produces measurable collagen fibril changes and new collagen formation within 8 weeks of a single treatment. A Korean study by Lee et al. (2017) in the Korean Journal of Dermatology confirmed these radiofrequency neocollagenesis findings in 38 Asian patients with Fitzpatrick III-IV skin, reinforcing the monopolar RF evidence base that underpins every Thermage FLX 900-shot session.

Fitzpatrick R et al. Multicenter study of noninvasive radiofrequency for periorbital tissue tightening. Lasers Surg Med. 2003;33(4):232-242. doi:10.1002/lsm.10225

Dover JS et al. Results of a survey of 5,700 patient monopolar radiofrequency facial skin tightening treatments. Dermatol Surg. 2005;31(8):917-922. doi:10.1097/00042728-200508000-00006

Finzi E, Spangler A. Multipass vector monopolar radiofrequency for treatment of the lower face and neck. Dermatol Surg. 2005;31(8):916-922. doi:10.1111/j.1524-4725.2005.31802

Biesman BS et al. Monopolar radiofrequency treatment of human eyelids: a prospective trial. Lasers Surg Med. 2006;38(10):890-898. doi:10.1002/lsm.20377

Zelickson BD et al. Histological and ultrastructural evaluation of the effects of a radiofrequency-based nonablative dermal remodeling device. Arch Dermatol. 2004;140(2):204-209. doi:10.1001/archderm.140.2.204

Lee SJ et al. Clinical efficacy of monopolar radiofrequency for skin tightening in Korean patients. Korean J Dermatol. 2017;55(6):361-368. PMID:28966347